Market Snapshot

BSE Sensex: 76664.21 -1.29%
BSE 500: 35349.66 -1.06%
BSE 200: 11074.32 -1.05%
BSE 100: 25300.66 -1.08%
BSE BANKEX: 63188.31 -0.44%
BSE IT: 27648.74 -5.13%
Nifty 50: 23897.95 -1.14%
Nifty 500: 22570.05 -1.06%
Nifty 200: 13656.85 -1.05%
Nifty 100: 24827.3 -1.07%
Nifty Midcap 100: 59374.8 -0.96%
Nifty Small 100: 17567.2 -0.87%
Nifty IT: 28530.6 -5.29%
Nifty PSU Bank: 8811.2 -0.15%

News:

Supreme Petrochem Q4 PAT jumps...
RBL Bank Q4 PAT spurts 234% Yo...
Lodha Developers Q4 PAT jumps ...
Axis Bank Q4 PAT marginally sl...
Mahindra Finance Q4 PAT climbs...

Tatva Chintan Pharma Chem Ltd Share Price – NSE / BSE
Chemicals, Small Cap

Invest

24 Apr 2026 | 03:59 PM

1,271.10

-40.05 (-3.05%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

66.94%

Return (1Y)

Beaten BSE Commodities by 52.19%
More Volatile

3.39%

Standard Deviation (1Y)

Higher than BSE Commodities by 2.25%
Not so consistent

6/12

Months

underperformed BSE Commodities
AxisDirect View

No View

52 Week High-Low

1,604

674

News & Announcements

Tatva Chintan Pharma Chem consolidated net profit rises 10735.71% in the December 2025 quarter
94 days ago

Tatva Chintan Pharma Chem consolidated net profit rises 10735.71% in the December 2025 quarter

21 - Jan - 2026 12:00 | 94 days ago

Net profit of Tatva Chintan Pharma Chem rose 10735.71% to Rs 15.17 crore in the quarter ended December 2025 as against Rs 0.14 crore during the previous quarter ended December 2024. Sales rose 52.89% to Rs 131.33 crore in the quarter ended December 2025 as against Rs 85.90 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 131.33 85.90 53

OPM % 19.41 8.22 -

PBDT 26.73 6.69 300

PBT 17.66 -0.24 LP

NP 15.17 0.14 10736

Powered by Capital Market - Live News
Tatva Chintan Pharma Chem to conduct board meeting
103 days ago

Tatva Chintan Pharma Chem to conduct board meeting

12 - Jan - 2026 12:00 | 103 days ago

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 21 January 2026.
Powered by Capital Market - Live News
Tatva Chintan Pharma Chem reports consolidated net profit of Rs 9.92 crore in the September 2025 quarter
176 days ago

Tatva Chintan Pharma Chem reports consolidated net profit of Rs 9.92 crore in the September 2025 quarter

31 - Oct - 2025 12:00 | 176 days ago

Net profit of Tatva Chintan Pharma Chem reported to Rs 9.92 crore in the quarter ended September 2025 as against net loss of Rs 0.66 crore during the previous quarter ended September 2024. Sales rose 47.95% to Rs 123.52 crore in the quarter ended September 2025 as against Rs 83.49 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 123.52 83.49 48

OPM % 17.98 6.68 -

PBDT 22.72 5.79 292

PBT 13.66 -1.02 LP

NP 9.92 -0.66 LP

Powered by Capital Market - Live News
Tatva Chintan Pharma drops on profit booking
184 days ago

Tatva Chintan Pharma drops on profit booking

23 - Oct - 2025 12:00 | 184 days ago

The stock had surged 34.45% over the past eight consecutive sessions, buoyed by renewed buying interest in specialty chemical names. The stock has surged 33.78% in three months, 74.94% in six months and 27.57% in one year.
Tatva Chintan Pharma Chem is primarily engaged in manufacturing, sale and distribution of specialty chemicals, viz., phase transfer catalysts (PTC), structure directing agents (SDA), electrolyte salts and solutions (ESS), pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC).
On a consolidated basis, net profit of Tatva Chintan Pharma Chem rose 27.64% to Rs 6.65 crore while net sales rose 10.81% to Rs 116.86 crore in Q1 June 2025 over Q1 June 2024.
The company will consider Q2 September 2025 results on Friday, 31 October 2025.

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Tatva Chintan Pharma Chem Ltd has decreased by -8.45% since past 3 Months
MF shareholding in Tatva Chintan Pharma Chem Ltd has decreased by -11.78% since past 3 Months
FII shareholding in Tatva Chintan Pharma Chem Ltd has increased by 15.69% since past 1 Year
MF shareholding in Tatva Chintan Pharma Chem Ltd has decreased by -46.25% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	131.33	85.90	53
OPM %	19.41	8.22	-
PBDT	26.73	6.69	300
PBT	17.66	-0.24	LP
NP	15.17	0.14	10736

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	123.52	83.49	48
OPM %	17.98	6.68	-
PBDT	22.72	5.79	292
PBT	13.66	-1.02	LP
NP	9.92	-0.66	LP

General Notifications

My Notifications

Research Notifications

Tatva Chintan Pharma Chem Ltd Share Price – NSE / BSE Chemicals, Small Cap

1,271.10 -40.05 (-3.05%)

News & Announcements

Price vs Volume

Stock Trivia

Tatva Chintan Pharma Chem Ltd Share Price – NSE / BSE
Chemicals, Small Cap

1,271.10

-40.05 (-3.05%)